{"product_id":"aevis-swot-analysis","title":"Aevis Victoria SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Strategic Toolkit Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eAevis Victoria combines a diversified healthcare and real estate portfolio with steady cash flows and niche market expertise, yet faces regulatory exposure and competitive pressures that could constrain growth; uncover how financials, market trends, and strategic levers interact in the full analysis. Purchase the complete SWOT report to access a professionally formatted Word and Excel package with research-backed insights, actionable recommendations, and editable tools for investment or strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDominant Swiss Healthcare Market Position\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAEVIS VICTORIA’s Swiss Medical Network is one of Switzerland’s largest private clinic groups, operating 27 hospitals and 70 outpatient sites across 10 cantons as of December 2025, driving CHF 1.1bn pro forma revenue in 2024; this scale yields meaningful economies of scale and a stronger negotiation stance with insurers and suppliers, while a decentralized model preserves local patient care and enables centralized procurement and IT efficiency.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Value Healthcare Real Estate Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpthrough its stake in infracore annual report aevis victoria controls a prime healthcare real estate portfolio worth chf delivering stable rental income that covered of group recurring revenue\u003e\n\u003cpthese purpose-built facilities clinics and long-term care sites highly specialized costly to replicate reducing competitive threat in switzerland keeping vacancy below\u003e\n\u003c\/pthese\u003e\u003c\/pthrough\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrestigious Luxury Hospitality Brand Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe Victoria-Jungfrau Collection anchors Aevis Victoria in the Swiss luxury segment with iconic hotels that in 2025 drew a wealthy mix of international and domestic guests, lifting average daily rates to roughly CHF 750 and RevPAR up ~18% vs 2019. By end-2025 the portfolio benefited from a sustained rebound in luxury travel and high-margin wellness tourism, helping luxury revenue grow an estimated 22% year-on-year. This high-end segment offers diversified, higher-margin revenue that complements the company’s defensive healthcare cash flows and reduces overall portfolio volatility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSynergistic Lifestyle and Wellness Integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpaevis victoria combines healthcare hospitality and lifestyle to target the european longevity preventive medicine market using private clinics luxury wellness retreats drive cross-sales increase arpu from high-net-worth clients.\u003e\n\u003cpits integrated model leverages clinical expertise and hospitality ops boosting occupancy clinic utilization in similar mixed models saw revenue uplift from bundled services.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTargets €250bn longevity market\u003c\/li\u003e\n\u003cli\u003eCross-sell raises ARPU by 12–18%\u003c\/li\u003e\n\u003cli\u003eAppeals to high-net-worth clientele\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pits\u003e\u003c\/paevis\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProven Strategic Investment Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe leadership has a track record of buying undervalued healthcare and real estate assets and adding value via operational upgrades and targeted capital; since 2018 Aevis Victoria has grown adjusted EBITDA from acquired assets by ~28% on average within 24 months.\u003c\/p\u003e\n\u003cp\u003eThe group’s multi‑year holding period fits capital‑intense healthcare and property cycles, helping preserve NAV during 2020–2023 volatility and delivering a compounded NAV per share gain of ~12% p.a.\u003c\/p\u003e\n\u003cp\u003eThe strategic discipline — rigorous underwriting, phased capex, and active asset management — enabled resilient cash flow and shareholder value through downturns.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAverage post‑acquisition EBITDA uplift ~28% (24 months)\u003c\/li\u003e\n\u003cli\u003eCompounded NAV per share ~12% p.a. (2018–2024)\u003c\/li\u003e\n\u003cli\u003eMulti‑year holding aligns with capital‑intensive assets\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAEVIS VICTORIA: CHF1.1bn healthcare platform with CHF2.3bn real‑estate and ~28% EBITDA lift\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAEVIS VICTORIA combines Switzerland’s large private clinic network (27 hospitals, 70 outpatient sites) and a CHF 2.3bn healthcare real‑estate stake (45.1% Infracore) to generate stable rental income and CHF 1.1bn pro forma revenue (2024), low vacancy (\u0026lt;3% 2024), luxury hotel RevPAR +18% vs 2019 (avg ADR CHF 750, 2025), and ~28% post‑acquisition EBITDA uplift (24 months).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals\/sites\u003c\/td\u003e\n\u003ctd\u003e27\/70\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePro forma rev 2024\u003c\/td\u003e\n\u003ctd\u003eCHF 1.1bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReal‑estate value\u003c\/td\u003e\n\u003ctd\u003eCHF 2.3bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVacancy 2024\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;3%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eADR 2025\u003c\/td\u003e\n\u003ctd\u003eCHF 750\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEBITDA uplift\u003c\/td\u003e\n\u003ctd\u003e~28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a clear SWOT framework analyzing Aevis Victoria’s internal capabilities and external market forces, highlighting strengths, weaknesses, opportunities, and threats that shape its strategic position.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise Aevis Victoria SWOT matrix for fast, visual strategy alignment, ideal for executives needing a snapshot of strategic positioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSignificant Debt and Capital Intensity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe group’s asset-heavy model needs large capex to keep medical devices and five-star hotel standards, with FY 2024 capex at CHF 112m and planned 2025–26 investments of ~CHF 180m.\u003c\/p\u003e\n\u003cp\u003eAs of 30 Sep 2025 Aevis Victoria reported net debt of CHF 1.15bn, driven by acquisitions and property development.\u003c\/p\u003e\n\u003cp\u003eRising rates raised FY 2025 finance costs to CHF 45m; a 100bp hike would add ~CHF 11m annually, squeezing net margins and cash flow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentration Risk in the Swiss Market\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDespite 86% of Aevis Victoria AG’s 2024 revenue coming from Switzerland, the group’s heavy reliance on the domestic market raises concentration risk; a Swiss GDP contraction of 1% could cut earnings materially. Any shift in federal healthcare funding—Switzerland spent CHF 94.1 billion on health in 2023—could disproportionately hit hospital and care segments. Limited geographic diversification outside Switzerland limits hedging against local systemic, regulatory, or demographic shocks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Sensitivity to Labor Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOperating in Switzerland exposes Aevis Victoria to some of the world’s highest labor costs: average healthcare wages in Switzerland rose to CHF 85,000–CHF 120,000 in 2024 for clinical staff, while hospitality wages averaged CHF 65,000, boosting payroll share to ~45% of operating expenses in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComplexity of Diversified Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eManaging Aevis Victoria’s mix of acute care hospitals, luxury hotels, and real estate development raises managerial complexity; in 2024 the group reported CHF 1.2bn in revenues across diversified segments, widening coordination needs.\u003c\/p\u003e\n\u003cp\u003eEach sector needs different expertise and regulation—healthcare faces strict clinical and reimbursement rules while hotels follow tourism cycles—raising compliance and market-risk costs.\u003c\/p\u003e\n\u003cp\u003eIf the corporate center misaligns with divisions, inefficiencies emerge: operating margin variance reached 480 basis points between segments in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRevenue mix CHF 1.2bn (2024)\u003c\/li\u003e\n\u003cli\u003e480 bp margin variance across segments (2024)\u003c\/li\u003e\n\u003cli\u003eThree distinct regulatory regimes: healthcare, hospitality, real estate\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDependency on Public Insurance Reimbursements\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpa substantial portion of aevis victoria revenue depends on swiss public tariffs tarmed and tardoc in about group clinical revenues were reimbursement-driven exposing the firm to tariff changes.\u003e\n\u003cpperiodic government revisions in the tarmed update that cut some specialist fees by cause sudden revenue swings and margin pressure.\u003e\n\u003cppolitical measures to curb healthcare spending keep private providers vulnerable a single tariff adjustment could alter annual ebitda by several percentage points.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~38% clinical revenue tied to public tariffs (2024)\u003c\/li\u003e\n\u003cli\u003e2023 TARMED fee reductions ~6% for some services\u003c\/li\u003e\n\u003cli\u003eTariff shifts can change EBITDA by multiple percentage points\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/ppolitical\u003e\u003c\/pperiodic\u003e\u003c\/pa\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh capex, CHF1.15bn debt and Swiss concentration raise tariff and financing risks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAsset-heavy model needs large capex (CHF 112m in FY2024; CHF ~180m planned 2025–26), net debt CHF 1.15bn (30 Sep 2025), rising finance costs (CHF 45m FY2025; +CHF 11m per 100bp), heavy Swiss concentration (86% revenue; CHF 1.2bn 2024) and ~38% clinical revenue tied to public tariffs—raising regulatory, labor-cost, and tariff-change risks.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2024 capex\u003c\/td\u003e\n\u003ctd\u003eCHF 112m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePlanned 2025–26\u003c\/td\u003e\n\u003ctd\u003e~CHF 180m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet debt\u003c\/td\u003e\n\u003ctd\u003eCHF 1.15bn (30 Sep 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2025 finance costs\u003c\/td\u003e\n\u003ctd\u003eCHF 45m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue concentration\u003c\/td\u003e\n\u003ctd\u003e86% Switzerland, CHF 1.2bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical tariffs exposure\u003c\/td\u003e\n\u003ctd\u003e~38% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eAevis Victoria SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality. The preview below is taken directly from the full SWOT report you'll get; once purchased, the complete, editable version is unlocked. You’re viewing a live excerpt of the real file, structured and ready to use immediately after checkout.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752213918073,"sku":"aevis-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/aevis-swot-analysis.png?v=1772238507","url":"https:\/\/matrixbcg.com\/products\/aevis-swot-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}